Search Results - "Lopez Vilella, R"

Idarucizumab in High-risk Thoracic Surgery by López-Vilella, R, Sanz-Sánchez, J, Sánchez-Lázaro, I, Marques-Sule, E, Rueda-Soriano, J, Almenar-Bonet, L

“…Direct oral anticoagulants have suggested a favorable profile compared with vitamin K antagonists. However, the lack of treatment to reverse the effect of…”
Get full text

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country by Lopez-Vilella, R, Gomez Bueno, M, Gonzalez Vflchez, F, Sole Jover, A, Laporta Hernandez, R, Vicente Guillen, R, Gonzalez Roman, A I, Sanchez-Lazaro, I, Hernandez Perez, F, Sales Badfa, G, Cordoba Pelaez, M D M, Torregrosa Puerta, S, teza Gil, A, Martinez Dolz, L, Segovia Cubero, J, Almenar Bonet, L

“…BackgroundThis study aims to evaluate the entire experience in heart-lung transplantation (HLTx) in a country of the European Union with 47 million inhabitants…”
Get full text

Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure by Ezzitouny, M., Sánchez-Lázaro, I., Rivera, M., Portolés-Sanz, M., Roselló-Lletí, E., Gil-Cayuela, C., Almenar-Bonet, L., López-Vilella, R., Ferré-Vallverdú, M., Sanz-Sánchez, J., Cerveró-Rubio, A., Jiménez-Aguilella, J.J., Pérez-Roselló, V., Donoso-Trenado, V., Arenas-Martín, P., Lozano-Edo, S., Jover-Pastor, P., Martínez-Dolz, L.

“…To evaluate whether the levels of some molecules implicated in nucleocytoplasmic transport in human cardiomyocytes are related to the severity of heart failure…”
Get full text

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country by López-Vilella, R, Bueno, M Gómez, Vílchez, F González, Jover, A Solé, Hernández, R Laporta, Guillén, R Vicente, Román, A I Gonzalez, Sánchez-Lázaro, I, Pérez, F Hernández, Badía, G Sales, Peláez, M D M Córdoba, Puerta, S Torregrosa, Gil, A teza, Dolz, L Martínez, Cubero, J Segovia, Bonet, L Almenar

“…HLTx presents notable differences with other transplants, especially related to its high mortality, which forces us to re-evaluate its usefulness according to…”
Get full text

Does the Calcineurin Inhibitor Have Influence on Cytomegalovirus Infection in Heart Transplantation? by Sanchez-Lazaro, I, Rodriguez-Serrano, M, Almenar-Bonet, L, Martinez Dolz, L, Lopez-Vilella, R, Portoles-Sanz, M, Rivera-Otero, M, Salvador-Sanz, A

Get full text

Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor by López-Vilella, R, Sánchez-Lázaro, I.J, Martínez-Dolz, L, Almenar-Bonet, L, Marqués-Sulé, E, Melero-Ferrer, J, Portolés-Sanz, M, Rivera-Otero, M, Domingo-Valero, D, Montero-Argudo, A

“…Abstract Background Development of obesity after heart transplantation (HT) is a common complication, largely attributed to immunosuppressive therapy. The…”
Get full text

Changes in self-care maintenance during quarantine in patients with heart failure by Klompstra, L, Almenar, L, Deka, P, Munoz-Gomez, E, Lopez-Vilella, R, Pathak, D, Westas, M, Marques-Sule, E

Get full text

(710) - Implications of Molecular Markers in Brain-Dead Donors in Primary Graft Dysfunction and Rejection After Heart Transplantation: The Potential Role of Preconditioning by Herrador-Galindo, L., Gonzalez-Costello, J., Niubo-Bosch, J., Farrero Torres, M., Maestro Benedicto, A., Blasco Peiro, T., Lopez-Vilella, R., Zatarain, E., Garrido Bravo, I., Gran Ipiña, F., Grande-Trillo, A., Manito, N., Moreno-Gonzalez, G.

Get full text

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction by Otero Garcia, O, De La Fuente Lopez, P, Sanchez-Lazaro, I, Donoso-Trenado, V, Yebra-Pimentel Brea, C, Lopez-Vilella, R, Adarraga-Gomez, J, Gallego-Latorre, G, Bouzas-Cruz, N, Garcia-Vega, D, Gomez-Otero, I, Almenar-Bonet, L, Gonzalez-Juanatey, J R

Get full text

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry by Garcia Vega, D, Donoso-Trenado, V, Otero-Garcia, O, Lopez-Vilella, R, Sanchez-Lazaro, I, Eiras, S, Delafuente-Lopez, P, Adarraga-Gomez, J, Gallego-Latorre, G, Yebra-Pimentel Brea, C, Bouzas-Cruz, N, Gomez-Otero, I, Almenar-Bonet, L, Gonzalez-Juanatey, J R

Get full text

Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes by Otero Garcia, O, Adarraga-Gomez, J, Donoso-Trenado, V, De La Fuente Lopez, P, Lopez-Vilella, R, Gallego-Latorre, G, Sanchez-Lazaro, I, Yebra-Pimentel Brea, C, Garcia-Vega, D, Bouzas-Cruz, N, Gomez-Otero, I, Almenar-Bonet, L, Gonzalez-Juanatey, J R

Get full text

(1010) Donor-Derived Cell-Free DNA Correlates Well with NT-ProBNP in Heart Transplant Recipients Undergoing Routine Endomyocardial Biopsies During First Year Post-Heart Transplant by Jimenez-Blanco Bravo, M., Crespo-Leiro, M., Garcia-Cosio, M., Perez-Gomez, L., Lopez-Vilella, R., Ortiz Bautista, C., Farrero Torres, M., Benedicto, A. Maestro, Molina, B. Diaz, Diez-Lopez, C., Sousa, D. Rangel, Salterain, N., Bravo, I. Garrido, Segovia-Cubero, J.

“…Donor-derived cell-free DNA (dd-cfDNA) has shown a good ability to rule out acute cellular rejection (ACR) in heart transplant (HT) recipients, and is thus a…”
Get full text

(1006) Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study) by Jimenez-Blanco Bravo, M., Crespo-Leiro, M., Garcia-Cosio, M., Perez-Gomez, L., Lopez-Vilella, R., Ortiz Bautista, C., Farrero Torres, M., Maestro Benedicto, A., Diaz Molina, B., Diez-Lopez, C., Rangel Sousa, D., Salterain, N., Garrido Bravo, I., Segovia-Cubero, J.

“…There is a clear need for a non-invasive biomarker that could allow surveillance of acute cellular rejection (ACR) without the need of repeated endomyocardial…”
Get full text

Musculoskeletal disorders in men and women with heart transplantation. A cross- sectional study by Moreno Segura, N, Almenar-Bonet, L, Fuentes-Aparicio, L, Atef, H, Escudero, P, Mesa-Rico, R, Lopez-Vilella, R, Pallares, P, Sentandreu-Mano, T, Berga-Congost, G, Sillero-Sillero, A, Marques-Sule, E

Get full text

Kinesiophobia in heart transplantation patients: a cross-sectional study with a special focus in sex differences by Moreno Segura, N, Almenar-Bonet, L, Fuentes-Aparicio, L, Atef, H, Escudero, S, Escudero, P, Lopez-Vilella, R, Sentandreu-Mano, T, Pallares, P, Mesa-Rico, R, Berga-Congost, G, Sillero-Sillero, A, Marques-Sule, E

Get full text

Clinical Utility of the IMPACT Score for Mortality Prediction after Heart Transplantation: External Validation Study by Bautista, C.D. Ortiz, Garcia, J. Muniz, Gonzalez-Vilchez, F., Cubero, J. Segovia, Leiro, M.G. Crespo, Vilella, R. Lopez, Costelo, J. Gonzalez, Minguel, E. Roig, Prado, J.M. Arizon Del, Marquez, J.M. Sobrino, Bravo, I.P. Garrido, Jimenez, J.F. Delgado

“…The primary objective of this work is to externally validate the Index for Mortality Prediction After Cardiac Transplantation (IMPACT) score in the Spanish…”
Get full text

HIT Poster session 3Transcatheter procedures (TAVI/MitralClip)P937Comparison between 3d transesophageal echocardiography and multislice computed tomography for the aortic annulus sizing in tavi patients: implication for prosthesis sizingP938Left ventricular remodelling in chronic mitral regurgitation: from geometry to mechanics by speckle tracing imageP939Direct TAVI of a self-expanding bioprosthesis: long-term clinical outcomes.P940Prognostic value of coronary flow reserve in the culprit artery by Stella, S, Li, H, Stathogiannis, K, Stojkovic, S, Ondrus, T, Plaza Lopez, D, Jinno, S, Verseckaite, R, Oliveira Da Silva, C, Altin, C, Krestjyaninov, MV, Izci, S, Santos, M, Urbano-Moral, JA, Spartera, M, Gonzalvez-Garcia, A, Miskowiec, D, Hagrass, MUHAMMAD, Rady, M, Reskovic Luksic, V, Castaldi, B, Silva, T, Kolossvary, M, Basuoni, A, Peovska Mitevska, I, Aguiar Rosa, S, Rosa, I, Marini, C, Ancona, F, Spagnolo, P, Latib, A, Romano, V, Colombo, A, Margonato, A, Agricola, E, Yuan, L, Xie, MX, Jin, XY, Toutouzas, K, Drakopoulou, M, Latsios, G, Synetos, A, Sanidas, E, Kaitozis, O, Trantalis, G, Gerckens, U, Tousoulis, D, Tesic, M, Stepanovic, J, Trifunovic, D, Beleslin, B, Giga, V, Nedeljkovic, I, Djordjevic Dikic, A, Bartunek, J, Vanderheyden, M, Stockman, B, Mirica, C, Kotrc, M, Van Praet, F, Van Camp, G, Penicka, M, Igual Munoz, B, Sanchez Lacuesta, ME, Lopez Vilella, R, Domenech Tort, MD, Sepulveda Sanchis, P, Ten Morro, F, Calvillo Batlles, P, Montero Argudo, JA, Martinez Dolz, LV, Yamada, A, Sugimoto, K, Ito, S, Kato, M, Inuzuka, H, Sugiyama, H, Takada, K, Ozaki, Y, Ishii, J, Mizariene, V, Gaileviciute, K, Bieseviciene, M, Jonkaitiene, R, Jurkevicius, R, Gunyeli, E, Winter, R, Back, M, Settergren, M, Manouras, A, Shahgaldi, K, Ozsoy, HM, Gezmis, E, Yilmaz, M, Tunc, E, Sade, LE, Muderrisoglu, H, Gimaev, RH, Melnikova, MA, Olezov, NV

Get full text

(556) Severity of Donor Transmitted Coronary Artery Disease and Survival after Heart Transplantation. Results from the Donor Coronary Artery Disease (DONOR-CAD) Study by Couto-Mallon, D., López-Vilella, R., Barge-Caballero, E., Hernández-Pérez, F., García, J. López-Azor, Gardeta, T. Domingo, Castel, M.A., de Antonio, M., Bravo, I. Garrido, Diez-Lopez, C., Anton, R. Manrique, Granados, A. López, Muñiz, J., Crespo-Leiro, M.G.

“…It is not known whether donor-transmitted coronary artery (DTCAD) disease after heart transplantation (HT) and its severity have prognostic implications. Our…”
Get full text

Poster session Thursday 12 December - AM: 12/12/2013, 08:30-12:30 Location: Poster area by Abdovic, E., Abdovic, S., Hristova, K., Katova, T., Gocheva, N., Pavlova, M., Gurzun, M. M., Ionescu, A., Canpolat, U., Yorgun, H., Sunman, H., Sahiner, L., Kaya, E., Ozer, N., Tokgozoglu, L., Kabakci, G., Aytemir, K., Oto, A., Gonella, A., D'ascenzo, F., Casasso, F., Conte, E., Margaria, F., Grosso Marra, W., Frea, S., Morello, M., Bobbio, M., Gaita, F., Seo, H., Lee, S., Lee, J., Yoon, Y., Park, E., Kim, H., Park, S., Lee, H., Kim, Y., Sohn, D., Nemes, A., Domsik, P., Kalapos, A., Orosz, A., Lengyel, C., Forster, T., Enache, R., Muraru, D., Popescu, B., Calin, A., Nastase, O., Botezatu, D., Purcarea, F., Rosca, M., Beladan, C., Ginghina, C., Piasentini, E., Mihaila, S., Padayattil Jose', S., Peluso, D., Ucci, L., Naso, P., Puma, L., Iliceto, S., Badano, L., Cikes, M., Jakus, N., Sutherland, G., Haemers, P., D'hooge, J., Claus, P., Yurdakul, S., Oner, F., Direskeneli, H., Sahin, T., Cengiz, B., Ercan, G., Bozkurt, A., Aytekin, S., Osa Saez, A. M., Rodriguez-Serrano, M., Lopez-Vilella, R., Buendia-Fuentes, F., Domingo-Valero, D., Quesada-Carmona, A., Miro-Palau, V., Arnau-Vives, M., Palencia-Perez, M., Rueda-Soriano, J., Lipczynska, M., Piotr Szymanski, P., Anna Klisiewicz, A., Lukasz Mazurkiewicz, L., Piotr Hoffman, P., Kim, K., Cho, S., Ahn, Y., Jeong, M., Cho, J., Park, J., Chinali, M., Franceschini, A.

Get full text

Hyperkalemia in heart failure patients: current challenges and future prospects by Lopez-vilella, Raquel, Morillas-Climent, Herminio, Plaza-Lopez, Diego, Cebrian-Pinar, Monica, Sanchez-Lazaro, Ignacio, Almenar-Bonet, Luis

“…In heart failure (HF), hyperkalemia is a frequent problem because of several factors, such as neurohormonal mechanisms involved in the disease, renal failure,…”
Get full text